CHEONGJU, South Korea, September 17, 2025--(BUSINESS WIRE)--Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral ...
Strengthen the PFS CMO business through a long-term partnership with global syringe leader BD Expand the global customer network by leveraging the BD&CMO Partnership Program Triple production capacity ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する